Dianne Augelli, MD
Internal Medicine · New York, NYNPI 1609956473
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $255,250 of the $255,350 with a category attached, or 100.0%. SNAP Diagnostics LLC accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $59,200, 2.2 times the $27,000 reported in 2019. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 8 payments — averaging $31,919 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SNAP Diagnostics LLC$255K
- Jazz Pharmaceuticals Inc.$100
What the payments were for
- Speaking & faculty fees$255,250100%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SNAP Diagnostics LLC | 7 | $255,250 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SNAP Diagnostics study$208,000
How this compares
$255,350 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NeuproRotigotine | 12 | $9,572 |
| Clonazepam | 16 | $290 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 15 | $287 |
| Pregabalin | 25 | $228 |
| Trazodone Hcl | 33 | $128 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.